Synthesis, Characterization, DFT Mechanistic Study, Antimicrobial Activity, Molecular Modeling, and ADMET Properties of Novel Pyrazole-isoxazoline Hybrids
Overview
Authors
Affiliations
A series of new heterocycle hybrids incorporating pyrazole and isoxazoline rings was successfully synthesized, characterized, and evaluated for their antimicrobial responses. The synthesized compounds were obtained utilizing -alkylation and 1,3-dipolar cycloaddition reactions, as well as their structures were established through spectroscopic methods and confirmed by mass spectrometry. To get more light on the regioselective synthesis of new hybrid compounds, mechanistic studies were performed using DFT calculations with B3LYP/6-31G(d,p) basis set. Additionally, the results of the preliminary screening indicate that some of the examined hybrids showed potent antimicrobial activity, compared to standard drugs. The results confirm that the antimicrobial activity is strongly dependent on the nature of the substituents linked pyrazole and isoxazoline rings. Furthermore, molecular docking studies were conducted to highlight the interaction modes between the investigated hybrid compounds and the and receptors. Notably, the results demonstrate that the investigated compounds have strong protein binding affinities. The stability of the formed complexes by the binding between the hybrid compound , and the target proteins was also confirmed using a 100 ns molecular dynamics simulation. Finally, the prediction of ADMET properties suggests that almost all hybrid compounds possess good pharmacokinetic profiles and no signs of observed toxicity, except for compounds , , and .
Grouli A, Chraka A, Bachra Y, Elkouali M, Chtita S, Berrada M Heliyon. 2024; 10(21):e39884.
PMID: 39583844 PMC: 11584581. DOI: 10.1016/j.heliyon.2024.e39884.
Rhazi Y, Sghyar R, Deak N, Es-Sounni B, Rossafi B, Soran A Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39459029 PMC: 11510333. DOI: 10.3390/ph17101390.
Shawish I, Al Ayoubi S, El-Faham A, Aldalbahi A, El-Senduny F, Badria F Front Chem. 2024; 12:1460384.
PMID: 39403698 PMC: 11471631. DOI: 10.3389/fchem.2024.1460384.
Majumdar D, Chatterjee A, Feizi-Dehnayebi M, Kiran N, Tuzun B, Mishra D Heliyon. 2024; 10(15):e35591.
PMID: 39170410 PMC: 11336723. DOI: 10.1016/j.heliyon.2024.e35591.
Arzine A, Hadni H, Boujdi K, Chebbac K, Barghady N, Rhazi Y Molecules. 2024; 29(14).
PMID: 39064944 PMC: 11279828. DOI: 10.3390/molecules29143366.